Celsius (NASDAQ:CELH - Get Free Report)'s stock had its "buy" rating reissued by equities research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $45.00 target price on the stock. Needham & Company LLC's target price points to a potential upside of 30.21% from the stock's previous close.
CELH has been the subject of a number of other reports. TD Cowen downgraded shares of Celsius from a "buy" rating to a "hold" rating and lowered their price target for the stock from $40.00 to $29.00 in a report on Wednesday, January 22nd. Piper Sandler lifted their price target on shares of Celsius from $43.00 to $44.00 and gave the company an "overweight" rating in a research report on Thursday, April 17th. Roth Mkm reissued a "buy" rating and issued a $38.00 target price on shares of Celsius in a research note on Friday, February 21st. UBS Group upped their price target on Celsius from $43.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Finally, Stifel Nicolaus reduced their price target on Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Celsius presently has an average rating of "Moderate Buy" and an average price target of $46.88.
Get Our Latest Stock Report on Celsius
Celsius Trading Down 2.7 %
CELH stock opened at $34.56 on Wednesday. The business has a 50 day simple moving average of $33.38 and a 200-day simple moving average of $29.58. Celsius has a twelve month low of $21.10 and a twelve month high of $98.85. The company has a market capitalization of $8.91 billion, a P/E ratio of 80.25, a PEG ratio of 2.90 and a beta of 1.65.
Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The firm had revenue of $329.28 million during the quarter, compared to analyst estimates of $349.09 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The business's revenue was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.27 EPS. Research analysts predict that Celsius will post 0.89 EPS for the current fiscal year.
Insider Activity
In related news, Director Joyce Russell sold 4,000 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the sale, the director now directly owns 19,106 shares in the company, valued at $543,947.82. This trade represents a 17.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at $1,167,303.69. This represents a 18.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Spire Wealth Management lifted its stake in shares of Celsius by 12.0% in the 1st quarter. Spire Wealth Management now owns 2,677 shares of the company's stock valued at $95,000 after purchasing an additional 287 shares during the period. Wealthcare Advisory Partners LLC increased its position in shares of Celsius by 3.2% during the first quarter. Wealthcare Advisory Partners LLC now owns 9,718 shares of the company's stock worth $346,000 after acquiring an additional 301 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of Celsius by 8.8% in the first quarter. TD Private Client Wealth LLC now owns 4,071 shares of the company's stock valued at $145,000 after purchasing an additional 328 shares in the last quarter. GAMMA Investing LLC lifted its stake in Celsius by 19.7% during the 1st quarter. GAMMA Investing LLC now owns 2,052 shares of the company's stock valued at $73,000 after acquiring an additional 338 shares in the last quarter. Finally, Moody National Bank Trust Division grew its position in Celsius by 1.3% in the 1st quarter. Moody National Bank Trust Division now owns 27,170 shares of the company's stock worth $968,000 after purchasing an additional 344 shares in the last quarter. Institutional investors own 60.95% of the company's stock.
About Celsius
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.